Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived mesenchymal stem cells plus fibrin glue versus fibrin glue for complex perianal fistulas without inflammatory bowel disease
2012-001178-28Phase 3Completed
- Sponsor
- FIBHULP
- Start
- Jun 2012
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of expanded adipose-derived stem cells in anal fistula (2 arms), sponsored by FIBHULP. Primary endpoints: Efficacy and safety and Fistula closure. Started Jun 2012; status: completed.
02
Drugs
expanded adipose-derived stem cells
03
Conditions
anal fistula
Beyond the preview
Go deeper on 2012-001178-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001178-28.